Respiratory Pharmacology Section 8- Anti-IL-5 Monoclonal Therapy

TOPICS: Benralizumab, blocks il-5 receptor, reslizumab, mepolizumab, block il-5 directly, decreased eosinophil differentiation development and survival, maintenance therapy for severe eosinophilic asthma
Go Back



Upgrade Now to Access All Content

Upgrade Now